Skip to main content
UniHealth

Doctor search

Armin J Bandari, MD

Cardiovascular Disease (Cardiology) · San Luis Obispo

NPI 1679750574

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2
Since medical school
24 years
Rush Medical College of Rush University, 2002

Offices

2 locations · Pacific Central Coast Health Centers · 247 clinicians in this group

Looking this up.

Hospitals listed: French Hospital Medical Center · Marian Regional Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bandari’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A105051 · Current

Licensed to practise in California · since 2008 · expires 2027-09-30 · Rush Medical College of Rush University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • French Hospital Medical CenterSan Luis Obispo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.23, Oct 2024 – Sep 2025
  • Marian Regional Medical CenterSanta Maria, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.67 (0.37 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.081, Oct 2024 – Sep 2025
See every measure and the patient survey for French Hospital Medical Center

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at French Hospital Medical Center
Clostridium Difficile (C.Diff)Infections0.23BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.89 (0 to 1.89) · 660 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.71 (0.39 to 1.04)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths154.33 (99.56 to 209.1) · 63 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 78 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.9 · 56 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.3 · 273 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths13.7 · 355 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.8 · 275 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.5 · 69 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.7 · 1,569 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.2 (0 to 0.4) · 4,085 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.07 to 0.47) · 4,358 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.69 (0.53 to 4.85) · 1,221 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.97 (0.47 to 3.48) · 567 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.54 (1.03 to 4.05) · 1,101 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.3 (0.36 to 12.23) · 585 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths3.66 (0.03 to 7.29) · 576 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.98 (0.5 to 3.47) · 185 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.2 (0 to 0.96) · 3,231 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.2 · 53 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections2.935No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.6 · 252 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 330 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-2.9 · 296 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-8.5 · 382 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits2 · 272 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.9 · 248 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.1 (3.2 to 8) · 25 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9.7 (6.5 to 14.1) · 25 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.5 · 40 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10 · 77 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 46 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.7 (8.9 to 15.1) · 837 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 706 casesNo differentJan 2024 – Dec 2024

What patients said (706 patients answered, 28% of those asked)

Patient survey stars by topic at French Hospital Medical Center
Cleanliness3
Nurse communication4
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness1
Recommend hospital5
Share of patients giving the best answer at French Hospital Medical Center
Room was "always" clean68%
Nurses "always" communicated well80%
Doctors "always" communicated well79%
Staff "always" explained62%
Yes, staff "did" give patients this information90%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications77%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully77%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night33%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects48%
Yes, staff "did" give patients information about possible symptoms91%
See every measure and the patient survey for Marian Regional Medical Center

Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Marian Regional Medical Center
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.67 (0.37 to 0.96)BetterJul 2022 – Jun 2024
Clostridium Difficile (C.Diff)Infections0.081BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.99 (0.06 to 1.93) · 1,191 casesNo differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths189.73 (139.29 to 240.17) · 66 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths3.7 · 103 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.8 · 161 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths15.9 · 247 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.7 · 478 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.4 · 470 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.5 · 237 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.5 · 3,050 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.14 (0 to 0.34) · 8,823 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.24 (0.05 to 0.42) · 8,672 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.87 (0.97 to 4.76) · 2,024 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.12 (0.57 to 3.67) · 782 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.29 (0.85 to 3.72) · 1,934 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths3.63 (0 to 9.97) · 787 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.01 (1.37 to 8.65) · 748 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.88 (0.43 to 3.32) · 373 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.13 (0 to 0.73) · 6,968 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 179 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.245No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.85No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.952No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.687No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.5 · 198 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.6 · 469 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits18.8 · 232 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.8 · 541 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-8.6 · 473 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 434 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.6 (5 to 8.4) · 519 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.9 (8.8 to 13.4) · 519 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.2 · 152 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11.3 · 83 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits18.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.2 to 17) · 124 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.9 to 1.4) · 638 casesNo differentJan 2024 – Dec 2024

What patients said (666 patients answered, 17% of those asked)

Patient survey stars by topic at Marian Regional Medical Center
Cleanliness4
Nurse communication4
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Marian Regional Medical Center
Room was "always" clean76%
Nurses "always" communicated well79%
Doctors "always" communicated well77%
Staff "always" explained64%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand72%
Doctors "always" listened carefully73%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)67%
Staff "always" explained new medications79%
Nurses "always" explained things so they could understand76%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital68%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$381,794

Medicare paid this office $381,794 for 1,716 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)774$88,157$96
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function404$66,321$158
Nuclear medicine studies of heart muscle at rest and with stress and spect174$65,359$376
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report117$21,729$186
Technetium tc-99m sestamibi, diagnostic, per study dose188$19,464$52
See all 33 services
Every Original Medicare service billed
Return visit (30+ min)774$88,157$96
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function404$66,321$158
Nuclear medicine studies of heart muscle at rest and with stress and spect174$65,359$376
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report117$21,729$186
Technetium tc-99m sestamibi, diagnostic, per study dose188$19,464$52
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function288$16,461$56
New patient visit (60+ min)98$15,933$163
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician189$10,397$55
Long return visit (40+ min)63$10,323$145
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report562$7,278$11
Initial hospital care with moderate level of medical decision making at least 75 minutes40$5,526$135
Ultrasound of heart blood flow, valves and chambers116$5,206$45
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days96$4,372$20
Ultrasound of both sides of head and neck blood flow26$3,929$146
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days49$3,672$18
Injection, perflutren lipid microspheres, per ml51$3,524$33
Injection, regadenoson, 0.1 mg140$3,276None
Heart rhythm review and interpretation of continous external ekg over 8-15 days152$3,038$20
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes21$2,909$91
Ultrasound of heart with color-depicted blood flow, rate and valve function121$2,580$21
Anticoagulant management of patient taking warfarin11$2,551$9
Programming of dual lead pacemaker system62$1,852$27
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days26$1,606$25
Heart rhythm recording of continous external ekg over 8-15 days152$1,602$11
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional17$946$56
Routine electrocardiogram (ecg) using at least 12 leads with tracing172$857$5
Office for the evaluation and management of established patient that may not require presence of healthcare professional12$807$19
Evaluation of cardiac rhythm monitor system, remote up to 30 days13$752$20
Programming of multiple lead implantable defibrillator system14$694$41
Injection of x-ray contrast during ultrasound of heart18$556$31
Programming of dual lead implantable defibrillator system11$451$41
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes13$126$10
Injection, aminophyllin, up to 250 mg13$90None

Who their Medicare patients are

1,716 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 18% · Women 45% · Also on Medicaid 10% · Health risk score 1.36. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.

Conditions among them: High blood pressure 75% · Atrial fibrillation 42% · Coronary heart disease 38% · Chronic kidney disease 29% · Heart failure 26% · Diabetes 25% · Depression 20% · Cancer 18% · COPD 16% · Stroke 12% · Dementia 6%.

The office billed $1,450,715, Medicare allowed $513,140 and paid $381,794; for 5,929 services of 61 kinds; $6,890 of it was for drugs given in the office and $374,905 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20241,7165,929771.36$1,450,715$381,794
20231,6105,882771.32$1,134,611$398,669
20221,5385,825771.29$1,113,990$394,979
20211,7016,425761.33$1,231,313$449,071
20201,4424,979761.42$1,051,780$336,100
20191,5516,220761.39$1,285,610$441,996
20181,3415,820761.42$1,159,377$388,682
20171,3496,149761.42$1,104,117$394,127
20161,2666,547761.41$1,151,260$372,676
20151,2586,515761.44$1,077,980$364,843
20141,1976,100761.41$1,008,282$337,631
20131,1405,884761.42$959,544$356,765

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 34 services

Original Medicare services billed in 2023
Return visit (30+ min)740$81,491$96
Nuclear medicine studies of heart muscle at rest and with stress and spect195$75,163$383
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function331$51,613$153
Injection, regadenoson, 0.1 mg158$27,599None
Technetium tc-99m sestamibi, diagnostic, per study dose194$21,102$54
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function348$20,125$56
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report102$18,894$185
New patient visit (60+ min)95$16,456$173
Long return visit (40+ min)72$11,519$139
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician194$10,339$53
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report638$8,192$11
Initial hospital care with moderate level of medical decision making at least 75 minutes40$5,420$136
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days65$4,653$22
Ultrasound of heart blood flow, valves and chambers101$4,483$44
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$4,208$98
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days25$4,011$19
Ultrasound of both sides of head and neck blood flow24$3,899$162
Injection, perflutren lipid microspheres, per ml44$3,075$35
Anticoagulant management of patient taking warfarin19$3,058$9
Heart rhythm review and interpretation of continous external ekg over 8-15 days144$2,674$18
Ultrasound of heart with color-depicted blood flow, rate and valve function112$2,328$21
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days21$1,840$27
Programming of dual lead pacemaker system49$1,538$28
Heart rhythm recording of continous external ekg over 8-15 days137$1,459$11
External shock to heart to regulate heart beat15$1,335$89
Ultrasound of heart, follow-up14$1,130$71
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional18$841$47
Ultrasound of heart, follow-up15$307$20
Routine electrocardiogram (ecg) using at least 12 leads with tracing51$280$5
Ultrasound of heart blood flow, valves and chambers, follow-up12$244$20
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes17$170$10
Injection, aminophyllin, up to 250 mg17$118None
Ultrasound of heart blood flow, valves and chambers, follow-up14$82$6
Ultrasound of heart with color-depicted blood flow, rate and valve function16$41$3

2022: 35 services

Original Medicare services billed in 2022
Return visit (30+ min)764$85,156$96
Nuclear medicine studies of heart muscle at rest and with stress and spect193$77,263$398
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function292$43,372$146
Injection, regadenoson, 0.1 mg159$30,879None
Long return visit (40+ min)130$21,246$137
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function290$17,623$58
Technetium tc-99m sestamibi, diagnostic, per study dose193$17,222$44
New patient visit (60+ min)72$11,428$159
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report53$10,612$200
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician193$10,324$53
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report700$8,446$11
Initial hospital care with moderate level of medical decision making at least 75 minutes51$8,163$160
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes40$6,589$84
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days71$4,756$22
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days30$4,496$21
Critical care, first 30-74 minutes14$3,576$179
Anticoagulant management of patient taking warfarin26$3,564$9
Short return visit (20+ min)34$2,609$75
Injection, perflutren lipid microspheres, per ml35$2,470$36
Ultrasound of heart blood flow, valves and chambers52$2,362$45
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days24$2,130$27
Ultrasound of both sides of head and neck blood flow12$2,062$172
Programming of dual lead pacemaker system56$1,684$28
Heart rhythm review and interpretation of continous external ekg over 8-15 days67$1,525$22
Heart rhythm recording of continous external ekg over 8-15 days89$1,171$13
Ultrasound of heart with color-depicted blood flow, rate and valve function52$1,113$21
Programming of dual lead implantable defibrillator system14$808$43
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional15$807$54
Programming of multiple lead implantable defibrillator system11$723$48
Office for the evaluation and management of established patient that may not require presence of healthcare professional13$546$17
Ultrasound of heart, follow-up18$399$21
Injection, aminophyllin, up to 250 mg24$200None
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes14$143$10
Ultrasound of heart blood flow, valves and chambers, follow-up18$108$6
Ultrasound of heart with color-depicted blood flow, rate and valve function23$63$3

2021: 33 services

Original Medicare services billed in 2021
Return visit (30+ min)856$106,465$99
Nuclear medicine studies of heart muscle at rest and with stress and spect168$70,125$417
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function336$55,968$162
Technetium tc-99m sestamibi, diagnostic, per study dose160$27,410$86
Injection, regadenoson, 0.1 mg138$26,263None
Long return visit (40+ min)142$23,807$143
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function394$23,691$59
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report61$12,335$202
New patient visit (60+ min)64$11,054$173
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report716$9,815$12
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician167$8,983$54
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes56$8,589$86
Initial hospital care with moderate level of medical decision making at least 75 minutes50$8,384$164
Anticoagulant management of patient taking warfarin25$5,480$9
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days75$5,462$23
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days32$4,728$21
Transitional care management services for problem of high complexity17$4,137$230
Injection, perflutren lipid microspheres, per ml43$3,550$38
Ultrasound of heart blood flow, valves and chambers59$2,733$46
Ultrasound of both sides of head and neck blood flow13$2,299$177
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days25$2,247$29
Heart rhythm review and interpretation of continous external ekg over 8-15 days96$2,067$21
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional28$1,838$66
Programming of dual lead pacemaker system54$1,779$30
Ultrasound of heart with color-depicted blood flow, rate and valve function59$1,319$22
Office for the evaluation and management of established patient that may not require presence of healthcare professional21$1,241$19
Heart rhythm recording of continous external ekg over 8-15 days81$1,066$13
Programming of dual lead implantable defibrillator system13$532$38
Ultrasound of heart, follow-up14$298$21
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes17$197$10
Injection, aminophyllin, up to 250 mg22$157None
Ultrasound of heart blood flow, valves and chambers, follow-up12$73$6
Ultrasound of heart with color-depicted blood flow, rate and valve function21$56$3

2020: 33 services

Original Medicare services billed in 2020
Return visit (30+ min)696$72,735$77
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function260$43,098$163
Nuclear medicine studies of heart muscle at rest and with stress and spect99$41,491$415
Long return visit (40+ min)198$24,767$107
Technetium tc-99m sestamibi, diagnostic, per study dose99$19,537$98
Injection, regadenoson, 0.1 mg80$15,312None
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function200$12,536$62
New patient visit (60+ min)70$11,156$159
Telephone medical discussion with physician, 21-30 minutes116$10,774$86
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report54$10,465$190
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes50$8,059$88
Initial hospital care with moderate level of medical decision making at least 75 minutes34$5,781$170
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician99$5,397$54
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report340$4,778$12
Telephone medical discussion with physician, 11-20 minutes75$4,594$60
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days70$4,089$24
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days28$3,927$21
Injection, perflutren lipid microspheres, per ml50$3,627$36
Anticoagulant management of patient taking warfarin25$3,610$10
Ultrasound of both sides of head and neck blood flow18$3,083$171
Ultrasound of heart blood flow, valves and chambers53$2,431$46
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days27$2,322$30
Office for the evaluation and management of established patient that may not require presence of healthcare professional43$2,212$14
Review and interpretation of external ekg recording for more than 48 hours up to 21 days86$1,992$22
New patient visit (45+ min)11$1,252$114
External ekg recording for more than 48 hours up to 21 days53$1,231$22
Programming of dual lead pacemaker system41$1,157$27
Ultrasound of heart with color-depicted blood flow, rate and valve function53$1,155$22
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional15$1,077$72
Ultrasound of heart, follow-up12$957$74
Blood test, clotting time30$600$4
Injection of x-ray contrast during ultrasound of heart14$398$28
Injection, aminophyllin, up to 250 mg11$71None

2019: 30 services

Original Medicare services billed in 2019
Nuclear medicine studies of heart muscle at rest and with stress and spect164$68,245$414
Return visit (30+ min)686$65,282$81
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function344$57,060$163
Long return visit (40+ min)316$44,264$114
Technetium tc-99m sestamibi, diagnostic, per study dose165$31,824$96
New patient visit (60+ min)206$30,618$149
Injection, regadenoson, 0.1 mg121$21,904None
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function230$14,245$61
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report74$13,917$188
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report844$13,213$13
Initial hospital care with moderate level of medical decision making at least 75 minutes71$12,158$167
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician164$8,752$53
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes60$8,505$85
Office for the evaluation and management of established patient that may not require presence of healthcare professional61$6,174$17
Transitional care management services for problem of high complexity23$4,341$189
Ultrasound of both sides of head and neck blood flow23$4,026$175
Injection, perflutren lipid microspheres, per ml44$3,441$37
Ultrasound of heart blood flow, valves and chambers73$3,378$46
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days48$3,057$22
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days26$2,923$20
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days27$2,489$33
External shock to heart to regulate heart beat19$2,058$89
Review and interpretation of external ekg recording for more than 48 hours up to 21 days88$1,811$21
External ekg recording for more than 48 hours up to 21 days80$1,810$23
Ultrasound of heart with color-depicted blood flow, rate and valve function73$1,607$22
Programming of dual lead pacemaker system44$1,607$31
Blood test, clotting time45$1,575$4
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional19$1,138$60
Programming of dual lead implantable defibrillator system12$630$48
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes22$264$10

2018: 32 services

Original Medicare services billed in 2018
Nuclear medicine studies of heart muscle at rest and with stress and spect187$77,832$414
Return visit (30+ min)582$59,503$77
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function279$47,406$165
Technetium tc-99m sestamibi, diagnostic, per study dose187$35,636$95
Injection, regadenoson, 0.1 mg128$22,555None
Long return visit (40+ min)160$20,978$108
New patient visit (60+ min)107$16,553$155
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function203$11,932$57
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report55$10,557$192
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report650$9,958$13
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician188$9,851$52
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes43$8,365$84
Office for the evaluation and management of established patient that may not require presence of healthcare professional120$8,189$16
Initial hospital care with moderate level of medical decision making at least 75 minutes38$6,484$162
Transitional care management services for problem of high complexity18$3,459$192
Ultrasound of heart, follow-up26$2,994$86
Critical care, first 30-74 minutes11$2,862$179
Blood test, clotting time115$2,503$5
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days46$2,482$22
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days21$2,461$42
Ultrasound of heart blood flow, valves and chambers52$2,400$46
Injection, perflutren lipid microspheres, per ml30$2,361$37
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days17$2,221$20
Ultrasound of both sides of head and neck blood flow13$2,050$158
External ekg recording for more than 48 hours up to 21 days60$1,364$23
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional19$1,350$71
Hospital discharge day management, more than 30 minutes15$1,320$88
Programming of dual lead pacemaker system39$1,228$29
Ultrasound of heart with color-depicted blood flow, rate and valve function53$1,173$22
External shock to heart to regulate heart beat11$1,083$83
Review and interpretation of external ekg recording for more than 48 hours up to 21 days50$1,078$22
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes19$212$10

2017: 32 services

Original Medicare services billed in 2017
Nuclear medicine studies of heart muscle at rest and with stress and spect176$72,720$411
Return visit (30+ min)603$66,252$78
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function296$54,537$181
Technetium tc-99m sestamibi, diagnostic, per study dose177$33,931$95
Long return visit (40+ min)167$21,164$105
New patient visit (60+ min)129$20,013$155
Injection, regadenoson, 0.1 mg113$19,519None
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function230$12,027$51
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report647$10,170$13
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician175$9,744$55
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report40$9,033$226
Office for the evaluation and management of established patient that may not require presence of healthcare professional149$8,731$14
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes54$8,630$85
Initial hospital care with moderate level of medical decision making at least 75 minutes51$8,536$164
Ultrasound of both sides of head and neck blood flow22$3,589$163
Blood test, clotting time142$3,448$5
Injection, perflutren lipid microspheres, per ml28$2,329$40
Programming of dual lead pacemaker system43$2,208$42
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days39$2,048$24
Transitional care management services for problem of high complexity11$1,968$179
Ultrasound of heart blood flow, valves and chambers41$1,875$46
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional26$1,630$63
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days45$1,630$20
External ekg recording for more than 48 hours up to 21 days66$1,472$22
Review and interpretation of external ekg recording for more than 48 hours up to 21 days66$1,409$21
Ultrasound of heart, follow-up13$1,255$97
External shock to heart to regulate heart beat14$1,251$83
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days12$1,143$52
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days19$1,042$20
Ultrasound of heart with color-depicted blood flow, rate and valve function41$892$22
Evaluation of implantable heart and blood vessel monitoring system11$328$16
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes14$160$10

2016: 34 services

Original Medicare services billed in 2016
Nuclear medicine studies of heart muscle at rest and with stress and spect167$69,282$410
Return visit (30+ min)573$67,121$76
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function243$45,504$181
Technetium tc-99m sestamibi, diagnostic, per study dose169$32,276$95
New patient visit (60+ min)128$19,750$154
Injection, regadenoson, 0.1 mg84$14,064None
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report64$14,040$219
Long return visit (40+ min)83$12,302$114
Office for the evaluation and management of established patient that may not require presence of healthcare professional164$11,308$15
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function211$10,476$49
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician168$9,409$55
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report586$9,260$13
Initial hospital care with moderate level of medical decision making at least 75 minutes50$8,367$164
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes45$4,971$84
Blood test, clotting time161$4,106$5
Ultrasound of both sides of head and neck blood flow19$3,086$162
Transitional care management services for problem of high complexity15$3,054$191
Ultrasound of heart blood flow, valves and chambers58$2,656$46
Programming of dual lead pacemaker system43$2,222$44
Injection, perflutren lipid microspheres, per ml22$1,777$40
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days32$1,613$24
External shock to heart to regulate heart beat16$1,608$100
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days40$1,529$19
External ekg recording for more than 48 hours up to 21 days70$1,497$21
Review and interpretation of external ekg recording for more than 48 hours up to 21 days71$1,493$21
Hospital discharge day management, more than 30 minutes16$1,311$82
Ultrasound of heart with color-depicted blood flow, rate and valve function59$1,285$22
Short return visit (20+ min)23$1,277$56
New patient visit (45+ min)11$1,267$115
Ultrasound of heart with probe in esophagus, with report11$1,193$99
Electrocardiogram (ecg) 2-day continuous23$454$20
Electrocardiogram (ecg) 2-day continuous with review by health care professional23$438$19
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)14$366None
Ultrasound of heart with color-depicted blood flow, rate and valve function16$45$3

2015: 34 services

Original Medicare services billed in 2015
Return visit (30+ min)509$66,293$77
Nuclear medicine studies of heart muscle at rest and with stress and spect153$62,864$408
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function214$40,571$181
Technetium tc-99m sestamibi, diagnostic, per study dose153$40,217$131
New patient visit (60+ min)120$18,858$157
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report60$13,251$221
Office for the evaluation and management of established patient that may not require presence of healthcare professional174$12,470$15
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function235$12,242$51
Injection, regadenoson, 0.1 mg66$11,097None
Initial hospital care with moderate level of medical decision making at least 75 minutes59$10,137$164
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician154$8,569$55
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes52$8,380$84
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report475$7,749$13
Ultrasound of both sides of head and neck blood flow37$6,341$171
Long return visit (40+ min)48$6,182$117
Blood test, clotting time173$4,514$5
Ultrasound of heart blood flow, valves and chambers61$2,808$46
Short return visit (20+ min)39$2,502$60
Programming of dual lead pacemaker system46$2,379$43
Ultrasound of heart, follow-up12$1,796$106
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days45$1,553$23
External shock to heart to regulate heart beat14$1,511$101
External ekg recording for more than 48 hours up to 21 days65$1,478$22
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days52$1,441$18
Ultrasound of heart with color-depicted blood flow, rate and valve function61$1,353$22
Review and interpretation of external ekg recording for more than 48 hours up to 21 days59$1,308$21
Injection, perflutren lipid microspheres, per ml14$1,129$42
Hospital discharge day management, more than 30 minutes11$966$88
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days14$672$21
Electrocardiogram (ecg) 2-day continuous26$552$21
Electrocardiogram (ecg) 2-day continuous with review by health care professional26$547$21
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)16$526None
Ultrasound of heart, follow-up11$233$19
Ultrasound of heart with color-depicted blood flow, rate and valve function14$45$3

2014: 29 services

Original Medicare services billed in 2014
Return visit (30+ min)546$68,446$75
Nuclear medicine studies of heart muscle at rest and with stress and spect130$52,522$404
Technetium tc-99m sestamibi, diagnostic, per study dose130$33,668$129
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function179$33,025$177
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function266$14,115$52
New patient visit (60+ min)92$13,878$151
Office for the evaluation and management of established patient that may not require presence of healthcare professional159$12,573$15
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report56$12,144$217
Initial hospital care with moderate level of medical decision making at least 75 minutes69$11,387$163
Long return visit (40+ min)71$10,675$110
Injection, regadenoson, 0.1 mg65$10,669None
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes58$8,888$84
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report464$7,834$13
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician130$7,088$55
Blood test, clotting time150$4,525$5
Ultrasound of both sides of head and neck blood flow27$4,334$161
Ultrasound of heart blood flow, valves and chambers56$2,513$45
Ultrasound of heart, follow-up20$2,390$100
Programming of dual lead pacemaker system34$1,715$40
Short return visit (20+ min)27$1,489$53
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days26$1,366$24
Review and interpretation of external ekg recording for more than 48 hours up to 21 days63$1,279$20
Ultrasound of heart with color-depicted blood flow, rate and valve function56$1,213$22
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days33$1,200$18
External ekg recording for more than 48 hours up to 21 days63$925$14
Electrocardiogram (ecg) 2-day continuous with review by health care professional20$410$21
Electrocardiogram (ecg) 2-day continuous20$409$20
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only11$83$6
Ultrasound of heart with color-depicted blood flow, rate and valve function15$45$3

2013: 33 services

Original Medicare services billed in 2013
Return visit (30+ min)513$79,756$78
Nuclear medicine studies of heart muscle at rest and with stress and spect129$54,578$417
Technetium tc-99m sestamibi, diagnostic, per study dose129$34,060$130
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function183$28,848$153
New patient visit (60+ min)122$18,297$150
Initial hospital care with moderate level of medical decision making at least 75 minutes103$16,834$157
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function314$15,646$49
Office for the evaluation and management of established patient that may not require presence of healthcare professional116$12,593$15
Long return visit (40+ min)86$11,845$111
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes76$11,744$82
Injection, regadenoson, 0.1 mg56$9,634None
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report494$9,076$14
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician129$7,398$56
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report38$6,840$180
Blood test, clotting time114$4,634$5
Critical care, first 30-74 minutes18$3,838$174
Ultrasound of both sides of head and neck blood flow23$3,496$152
Hospital discharge day management, more than 30 minutes40$3,399$83
Programming of dual lead pacemaker system38$2,192$41
Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270)12$2,072None
External shock to heart to regulate heart beat17$1,790$94
Ultrasound of heart, follow-up17$1,609$85
Ultrasound of heart blood flow, valves and chambers38$1,425$38
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days23$1,068$23
Short return visit (20+ min)23$1,055$46
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days26$955$19
Electrocardiogram (ecg) 2-day continuous34$805$24
Electrocardiogram (ecg) 2-day continuous with review by health care professional34$720$21
Ultrasound of heart with color-depicted blood flow, rate and valve function38$637$17
Review and interpretation of external ekg recording for more than 48 hours up to 21 days24$484$20
External ekg recording for more than 48 hours up to 21 days24$247$10
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only26$178$7
Ultrasound of heart with color-depicted blood flow, rate and valve function12$35$3

Medicaid work

$1,772 in 2024

Medicaid paid $1,772 for 14 billed services this clinician did in 2024, up to 13 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Return visit (30+ min)14$1,772
Medicaid work by year
202414113$1,772
2023101222$4,734
202252115$3,309
2021231326$18,727
202028215$2,074
201962313$6,499
201824112$2,373
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography89$4,633
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report12$101

2022

Largest Medicaid services in 2022
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography52$3,309

2021

Largest Medicaid services in 2021
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography179$13,638
Return visit (30+ min)33$4,874
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report19$215

2020

Largest Medicaid services in 2020
Return visit (30+ min)15$1,877
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report13$197

2019

Largest Medicaid services in 2019
Return visit (30+ min)25$3,221
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography24$3,059
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report13$219

2018

Largest Medicaid services in 2018
Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography24$2,373

Drugs they prescribed that Part D paid

$1,173,344

Pharmacies billed $1,173,344 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 4,251) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.

3,391 generic and 860 brand-name prescriptions · $1,173,344 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Eliquis459$638,081$1,390
Xarelto141$191,606$1,359
Entresto78$115,205$1,477
Repatha Sureclick63$59,679$947
Farxiga48$54,858$1,143
See all 46 drugs
Every Part D drug this clinician prescribed
Eliquis459$638,081$1,390
Xarelto141$191,606$1,359
Entresto78$115,205$1,477
Repatha Sureclick63$59,679$947
Farxiga48$54,858$1,143
Praluent14$20,298$1,450
Metoprolol751$14,347$19
Valsartan231$7,661$33
Atorvastatin339$4,958$15
Valsartan-Hydrochlorothiazide74$4,576$62
Rosuvastatin245$4,292$18
Diltiazem 24hr Er (Cd)83$4,185$50
Flecainide Acetate67$2,994$45
Carvedilol207$2,284$11
Amlodipine Besylate235$1,894$8
Labetalol50$1,664$33
Losartan124$1,446$12
Eplerenone15$1,157$77
Spironolactone133$1,127$8
Ezetimibe32$1,057$33
Ranolazine Er14$1,041$74
Potassium Chloride38$1,023$27
Losartan-Hydrochlorothiazide33$993$30
Isosorbide Mononitrate Er62$960$15
Furosemide95$904$10
Nebivolol11$839$76
Olmesartan Medoxomil47$788$17
Propafenone11$737$67
Diltiazem 24hr Er16$713$45
Diltiazem 24hr Er (Xr)19$711$37
Olmesartan-Hydrochlorothiazide13$588$45
Torsemide28$578$21
Clopidogrel42$563$13
Lisinopril78$490$6
Fenofibrate12$410$34
Amiodarone26$408$16
Irbesartan23$407$18
Sotalol15$345$23
Warfarin20$342$17
Pravastatin15$283$19
Digoxin12$261$22
Metoprolol24$172$7
Ramipril12$148$12
Nitroglycerin11$114$10
Simvastatin18$78$4
Hydrochlorothiazide23$46$2

Year by year

Part D prescribing by year
20244,2516240% (0)20%$1,173,344
20234,6006490% (0)22%$1,296,257
20225,0466950% (0)19%$1,250,805
20214,9956990% (0)19%$1,131,001
20204,8276370% (0)21%$1,002,299
20194,8006370% (0)21%$864,559
20184,689591None20%$725,094
20174,6675840% (0)24%$551,577
20164,8325500% (0)26%$509,147
20154,5354830% (0)28%$414,126
20144,684455NoneNone$394,618
20134,150418None31%$291,470

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 46 drugs

Part D drugs prescribed in 2023
Eliquis555$711,052$1,281
Xarelto182$246,837$1,356
Entresto56$85,434$1,526
Repatha Sureclick96$74,382$775
Farxiga20$26,447$1,322
Metoprolol775$20,907$27
Praluent14$20,745$1,482
Valsartan212$9,706$46
Rosuvastatin267$8,412$32
Diltiazem 24hr Er (Cd)100$7,674$77
Atorvastatin352$6,652$19
Valsartan-Hydrochlorothiazide73$5,684$78
Nebivolol17$4,182$246
Labetalol68$4,153$61
Amlodipine Besylate274$4,076$15
Olmesartan Medoxomil51$3,419$67
Carvedilol215$2,993$14
Losartan154$2,833$18
Flecainide Acetate50$2,595$52
Ezetimibe31$1,644$53
Spironolactone127$1,547$12
Eplerenone15$1,430$95
Amlodipine Besylate-Benazepril23$1,368$59
Furosemide112$1,266$11
Amiodarone39$1,231$32
Torsemide39$1,158$30
Enoxaparin11$1,095$100
Potassium Chloride30$1,052$35
Lisinopril87$1,017$12
Losartan-Hydrochlorothiazide31$943$30
Amlodipine-Valsartan11$941$86
Isosorbide Mononitrate Er42$836$20
Clopidogrel53$805$15
Olmesartan-Hydrochlorothiazide20$639$32
Diltiazem 24hr Er28$623$22
Hydralazine15$457$30
Digoxin17$401$24
Irbesartan25$341$14
Sotalol24$308$13
Ramipril17$293$17
Diltiazem 24hr Er (Xr)11$279$25
Warfarin14$209$15
Hydrochlorothiazide32$148$5
Metoprolol17$129$8
Pravastatin11$96$9
Simvastatin14$55$4

2022: 50 drugs

Part D drugs prescribed in 2022
Eliquis541$651,565$1,204
Xarelto193$263,428$1,365
Entresto66$77,534$1,175
Repatha Sureclick84$64,950$773
Praluent19$23,960$1,261
Metoprolol837$22,388$27
Pradaxa15$21,922$1,461
Farxiga14$12,989$928
Valsartan234$12,499$53
Rosuvastatin273$9,270$34
Diltiazem 24hr Er (Cd)103$8,685$84
Atorvastatin426$6,840$16
Valsartan-Hydrochlorothiazide90$6,170$69
Flecainide Acetate52$4,312$83
Olmesartan Medoxomil76$3,824$50
Labetalol60$3,540$59
Carvedilol237$3,222$14
Losartan159$3,204$20
Eplerenone21$3,160$150
Amlodipine Besylate306$2,707$9
Nebivolol18$2,634$146
Digoxin36$1,665$46
Spironolactone135$1,506$11
Ezetimibe35$1,470$42
Olmesartan-Hydrochlorothiazide22$1,424$65
Losartan-Hydrochlorothiazide39$1,212$31
Fenofibrate14$1,209$86
Torsemide42$1,188$28
Clopidogrel58$1,178$20
Amlodipine Besylate-Benazepril24$1,142$48
Furosemide143$1,135$8
Amlodipine-Valsartan13$1,120$86
Potassium Chloride31$917$30
Isosorbide Mononitrate Er41$895$22
Diltiazem 24hr Er18$879$49
Lisinopril107$852$8
Nifedipine Er11$776$71
Dilt-Xr17$747$44
Amiodarone24$620$26
Warfarin23$542$24
Sotalol24$497$21
Nitroglycerin22$345$16
Pravastatin18$322$18
Hydralazine13$312$24
Hydrochlorothiazide49$284$6
Ramipril17$263$15
Atenolol16$219$14
Metoprolol28$216$8
Simvastatin20$190$9
Lisinopril-Hydrochlorothiazide15$128$9

2021: 51 drugs

Part D drugs prescribed in 2021
Eliquis517$599,355$1,159
Xarelto223$275,381$1,235
Repatha Sureclick70$48,690$696
Entresto35$37,293$1,066
Praluent36$22,450$624
Metoprolol804$20,940$26
Pradaxa13$16,519$1,271
Valsartan175$12,408$71
Diltiazem 24hr Er (Cd)100$8,596$86
Rosuvastatin266$7,886$30
Atorvastatin407$6,842$17
Bystolic17$6,595$388
Valsartan-Hydrochlorothiazide102$6,201$61
Olmesartan Medoxomil74$5,221$71
Losartan197$4,378$22
Flecainide Acetate55$4,259$77
Labetalol60$3,730$62
Dilt-Xr41$3,367$82
Amlodipine Besylate327$2,689$8
Carvedilol217$2,639$12
Digoxin47$2,413$51
Eplerenone18$2,399$133
Spironolactone126$1,446$11
Potassium Chloride43$1,406$33
Fenofibrate19$1,342$71
Ezetimibe33$1,211$37
Olmesartan-Hydrochlorothiazide20$1,158$58
Torsemide43$1,134$26
Clopidogrel72$1,102$15
Lisinopril129$1,097$9
Furosemide143$1,053$7
Ranolazine Er11$1,037$94
Amlodipine-Valsartan12$1,013$84
Losartan-Hydrochlorothiazide34$969$29
Diltiazem 24hr Er16$870$54
Warfarin32$861$27
Amlodipine Besylate-Benazepril24$830$35
Amiodarone24$816$34
Isosorbide Mononitrate Er35$619$18
Nitroglycerin27$560$21
Cartia Xt14$552$39
Hydralazine18$488$27
Sotalol25$468$19
Chlorthalidone11$386$35
Irbesartan18$354$20
Metoprolol28$312$11
Pravastatin24$307$13
Hydrochlorothiazide33$233$7
Ramipril11$193$18
Lisinopril-Hydrochlorothiazide11$148$13
Simvastatin20$100$5

2020: 50 drugs

Part D drugs prescribed in 2020
Eliquis501$506,505$1,011
Xarelto251$265,487$1,058
Repatha Sureclick47$27,941$594
Entresto26$26,797$1,031
Metoprolol705$22,067$31
Praluent16$15,865$992
Rosuvastatin248$11,751$47
Pradaxa14$11,677$834
Valsartan153$11,660$76
Diltiazem 24hr Er (Cd)89$10,409$117
Atorvastatin422$8,406$20
Brilinta14$6,073$434
Valsartan-Hydrochlorothiazide87$5,688$65
Bystolic13$4,644$357
Losartan212$4,029$19
Labetalol60$3,740$62
Olmesartan Medoxomil68$3,621$53
Ranolazine Er21$3,548$169
Eplerenone18$3,370$187
Flecainide Acetate25$3,280$131
Dilt-Xr23$2,725$118
Carvedilol257$2,709$11
Amlodipine Besylate305$2,437$8
Lisinopril159$1,637$10
Midodrine11$1,619$147
Olmesartan-Hydrochlorothiazide28$1,608$57
Digoxin34$1,481$44
Spironolactone121$1,464$12
Potassium Chloride54$1,411$26
Amlodipine-Valsartan14$1,297$93
Irbesartan23$1,284$56
Clopidogrel76$1,108$15
Diltiazem 24hr Er21$1,057$50
Ezetimibe16$1,032$65
Cartia Xt23$1,003$44
Furosemide148$1,002$7
Torsemide45$988$22
Warfarin49$979$20
Amlodipine Besylate-Benazepril26$886$34
Sotalol25$706$28
Losartan-Hydrochlorothiazide28$608$22
Nitroglycerin13$554$43
Isosorbide Mononitrate Er26$452$17
Cilostazol11$436$40
Amiodarone13$416$32
Pravastatin23$414$18
Hydrochlorothiazide47$268$6
Lisinopril-Hydrochlorothiazide13$189$15
Metoprolol20$146$7
Simvastatin16$58$4

2019: 52 drugs

Part D drugs prescribed in 2019
Eliquis450$397,371$883
Xarelto254$231,886$913
Metoprolol708$28,101$40
Repatha Sureclick21$21,698$1,033
Praluent19$16,086$847
Rosuvastatin246$15,325$62
Diltiazem 24hr Er (Cd)77$10,610$138
Atorvastatin431$10,186$24
Entresto17$9,738$573
Valsartan111$7,489$67
Ranolazine Er20$6,864$343
Olmesartan Medoxomil92$6,764$74
Brilinta12$6,704$559
Bystolic19$5,426$286
Eplerenone25$4,538$182
Flecainide Acetate42$4,061$97
Potassium Chloride65$4,020$62
Labetalol54$3,769$70
Carvedilol290$3,722$13
Valsartan-Hydrochlorothiazide68$3,128$46
Losartan193$2,479$13
Dilt-Xr25$2,357$94
Amlodipine Besylate258$2,343$9
Cartia Xt47$2,270$48
Diltiazem 24hr Er22$1,890$86
Spironolactone122$1,685$14
Lisinopril178$1,655$9
Toprol Xl29$1,618$56
Warfarin68$1,410$21
Digoxin34$1,396$41
Amlodipine-Valsartan18$1,302$72
Amiodarone16$1,214$76
Torsemide59$1,206$20
Furosemide176$1,191$7
Olmesartan-Hydrochlorothiazide17$1,012$60
Clopidogrel73$957$13
Ezetimibe11$911$83
Amlodipine Besylate-Benazepril13$903$69
Irbesartan18$854$47
Telmisartan12$786$66
Sotalol19$772$41
Losartan-Hydrochlorothiazide40$635$16
Pravastatin30$571$19
Pantoprazole16$287$18
Isosorbide Mononitrate Er16$281$18
Lisinopril-Hydrochlorothiazide11$185$17
Benazepril13$152$12
Ramipril11$120$11
Hydrochlorothiazide27$120$4
Simvastatin15$120$8
Metoprolol14$51$4
Cilostazol13$40$3

2018: 46 drugs

Part D drugs prescribed in 2018
Eliquis362$278,240$769
Xarelto256$199,125$778
Metoprolol677$30,226$45
Repatha Sureclick19$29,484$1,552
Praluent21$25,674$1,223
Pradaxa28$18,971$678
Atorvastatin424$10,293$24
Rosuvastatin216$9,872$46
Diltiazem 24hr Er (Cd)71$7,437$105
Olmesartan Medoxomil97$6,456$67
Potassium Chloride67$5,837$87
Valsartan145$5,786$40
Eplerenone27$4,816$178
Flecainide Acetate43$4,516$105
Labetalol65$3,624$56
Valsartan-Hydrochlorothiazide86$3,337$39
Carvedilol296$3,031$10
Warfarin125$2,632$21
Coumadin12$2,331$194
Cartia Xt47$2,298$49
Amlodipine Besylate232$2,115$9
Amlodipine-Valsartan22$1,839$84
Losartan141$1,721$12
Torsemide71$1,688$24
Spironolactone121$1,612$13
Olmesartan-Hydrochlorothiazide19$1,596$84
Digoxin23$1,517$66
Ezetimibe14$1,492$107
Lisinopril192$1,416$7
Amlodipine Besylate-Benazepril12$1,098$92
Clopidogrel70$1,098$16
Diltiazem 24hr Er12$1,084$90
Toprol Xl16$933$58
Losartan-Hydrochlorothiazide48$919$19
Furosemide148$799$5
Telmisartan11$775$70
Isosorbide Mononitrate Er21$574$27
Irbesartan13$559$43
Amiodarone19$559$29
Sotalol12$429$36
Pravastatin25$389$16
Pantoprazole35$346$10
Hydrochlorothiazide31$185$6
Simvastatin24$175$7
Lisinopril-Hydrochlorothiazide20$172$9
Hydralazine14$94$7

2017: 45 drugs

Part D drugs prescribed in 2017
Eliquis262$183,036$699
Xarelto260$161,804$622
Metoprolol636$25,664$40
Repatha Sureclick21$24,798$1,181
Pradaxa22$17,330$788
Atorvastatin484$11,056$23
Rosuvastatin185$8,889$48
Ranexa15$7,691$513
Valsartan210$7,118$34
Diltiazem 24hr Cd13$5,814$447
Flecainide Acetate58$4,967$86
Diltiazem 24hr Er63$4,462$71
Potassium Chloride72$4,462$62
Crestor12$4,279$357
Valsartan-Hydrochlorothiazide90$3,720$41
Labetalol54$3,633$67
Eplerenone21$3,373$161
Dofetilide12$2,947$246
Carvedilol251$2,673$11
Warfarin154$2,656$17
Coumadin13$2,258$174
Digoxin44$2,247$51
Cartia Xt52$2,096$40
Amlodipine Besylate244$1,875$8
Amlodipine-Valsartan25$1,865$75
Spironolactone152$1,814$12
Fenofibrate18$1,763$98
Lisinopril224$1,506$7
Clopidogrel85$1,451$17
Losartan122$1,269$10
Isosorbide Mononitrate Er39$1,179$30
Amiodarone51$1,115$22
Torsemide35$1,111$32
Digox13$1,104$85
Losartan-Hydrochlorothiazide58$986$17
Telmisartan15$916$61
Furosemide159$814$5
Pantoprazole46$607$13
Pravastatin23$316$14
Simvastatin34$253$7
Lisinopril-Hydrochlorothiazide23$239$10
Hydrochlorothiazide28$190$7
Lovastatin14$164$12
Triamterene-Hydrochlorothiazid11$153$14
Atenolol17$138$8

2016: 51 drugs

Part D drugs prescribed in 2016
Xarelto255$147,594$579
Eliquis168$96,234$573
Crestor122$46,727$383
Pradaxa48$33,918$707
Metoprolol653$23,306$36
Repatha Sureclick12$22,233$1,853
Diltiazem 24hr Er90$16,307$181
Valsartan177$13,627$77
Atorvastatin490$12,460$25
Rosuvastatin68$8,623$127
Zetia19$6,701$353
Ranexa18$5,769$321
Potassium Chloride100$5,193$52
Valsartan-Hydrochlorothiazide130$4,485$35
Effient11$4,192$381
Labetalol68$4,054$60
Eplerenone29$4,027$139
Carvedilol270$2,833$10
Flecainide Acetate53$2,630$50
Warfarin175$2,579$15
Amlodipine-Valsartan26$2,391$92
Digoxin47$2,173$46
Amlodipine Besylate260$2,123$8
Spironolactone165$1,852$11
Fenofibrate19$1,699$89
Losartan134$1,658$12
Lisinopril209$1,628$8
Torsemide63$1,534$24
Clopidogrel85$1,423$17
Amiodarone67$1,317$20
Cartia Xt30$1,266$42
Bumetanide12$1,265$105
Amlodipine Besylate-Benazepril16$1,265$79
Enoxaparin12$1,160$97
Telmisartan15$1,156$77
Nitrostat15$932$62
Toprol Xl13$877$67
Furosemide156$802$5
Pantoprazole49$743$15
Losartan-Hydrochlorothiazide54$719$13
Simvastatin72$618$9
Isosorbide Mononitrate Er23$492$21
Spironolactone-Hctz12$448$37
Diltiazem 24hr Cd14$447$32
Pravastatin17$361$21
Hydrochlorothiazide36$254$7
Triamterene-Hydrochlorothiazid19$220$12
Klor-Con 1012$172$14
Lovastatin11$161$15
Atenolol28$157$6
Lisinopril-Hydrochlorothiazide18$97$5

2015: 47 drugs

Part D drugs prescribed in 2015
Xarelto215$102,530$477
Crestor191$63,685$333
Eliquis125$60,759$486
Pradaxa52$33,101$637
Metoprolol670$25,936$39
Diltiazem 24hr Er92$14,966$163
Atorvastatin418$11,984$29
Valsartan82$11,115$136
Zetia38$8,830$232
Ranexa16$5,019$314
Potassium Chloride133$4,914$37
Labetalol103$4,757$46
Valsartan-Hydrochlorothiazide115$4,454$39
Fenofibrate16$3,116$195
Eplerenone18$2,920$162
Diovan13$2,911$224
Telmisartan13$2,784$214
Flecainide Acetate30$2,547$85
Amlodipine Besylate300$2,539$8
Warfarin132$2,351$18
Carvedilol244$2,248$9
Diltiazem 24hr Cd22$2,205$100
Digoxin46$2,164$47
Amiodarone61$1,799$29
Amlodipine-Valsartan13$1,758$135
Lisinopril235$1,624$7
Losartan149$1,530$10
Amlodipine Besylate-Benazepril23$1,430$62
Torsemide59$1,308$22
Spironolactone124$1,056$9
Cartia Xt21$1,044$50
Clopidogrel76$1,028$14
Diltiazem Er14$949$68
Furosemide159$884$6
Toprol Xl12$789$66
Simvastatin66$644$10
Fenofibrate16$642$40
Losartan-Hydrochlorothiazide46$642$14
Pantoprazole39$631$16
Pravastatin15$568$38
Isosorbide Mononitrate Er20$466$23
Nitrostat16$436$27
Triamterene-Hydrochlorothiazid22$277$13
Hydrochlorothiazide27$201$7
Atenolol18$136$8
Metoprolol12$130$11
Ramipril16$120$8

2014: 50 drugs

Part D drugs prescribed in 2014
Xarelto200$81,162$406
Crestor200$63,382$317
Pradaxa75$39,816$531
Metoprolol681$29,244$43
Eliquis69$26,921$390
Atorvastatin381$12,409$33
Exforge42$11,552$275
Diltiazem 24hr Cd50$10,679$214
Diovan44$9,894$225
Diltiazem 24hr Er123$6,958$57
Labetalol136$5,820$43
Valsartan30$5,540$185
Potassium Chloride132$4,953$38
Fenofibrate24$4,800$200
Amiodarone73$4,376$60
Zetia18$3,504$195
Digoxin66$3,475$53
Amlodipine Besylate373$3,313$9
Valsartan-Hydrochlorothiazide37$2,845$77
Clopidogrel124$2,559$21
Losartan205$2,164$11
Amlodipine Besylate-Benazepril41$2,158$53
Carvedilol204$2,084$10
Benicar11$1,803$164
Warfarin128$1,741$14
Coumadin13$1,717$132
Flecainide Acetate27$1,712$63
Diltiazem Er21$1,644$78
Torsemide44$1,617$37
Lisinopril182$1,234$7
Digox33$1,205$37
Toprol Xl17$1,057$62
Furosemide202$1,038$5
Simvastatin95$884$9
Taztia Xt14$820$59
Losartan-Hydrochlorothiazide45$645$14
Isosorbide Mononitrate Er28$637$23
Spironolactone51$631$12
Fenofibrate16$546$34
Triamterene-Hydrochlorothiazid27$362$13
Levothyroxine25$342$14
Nitrostat20$312$16
Pantoprazole27$306$11
Felodipine Er12$283$24
Pravastatin14$273$19
Hydrochlorothiazide49$253$5
Lisinopril-Hydrochlorothiazide13$208$16
Ramipril12$181$15
Metoprolol21$169$8
Atenolol15$116$8

2013: 50 drugs

Part D drugs prescribed in 2013
Pradaxa158$58,056$367
Crestor185$42,724$231
Xarelto103$36,019$350
Metoprolol600$25,079$42
Diovan63$13,223$210
Atorvastatin312$11,789$38
Exforge22$7,305$332
Effient19$6,614$348
Diltiazem 24hr Er98$5,543$57
Labetalol129$5,173$40
Amlodipine Besylate334$4,127$12
Fenofibrate23$4,097$178
Valsartan-Hydrochlorothiazide27$3,815$141
Clopidogrel94$3,147$33
Tikosyn12$3,106$259
Coreg Cr12$2,792$233
Losartan158$2,662$17
Carvedilol198$2,633$13
Amiodarone76$2,446$32
Potassium Chloride77$2,346$30
Plavix11$2,196$200
Flecainide Acetate29$2,152$74
Diltiazem Er38$1,999$53
Lisinopril266$1,901$7
Warfarin127$1,882$15
Eplerenone13$1,850$142
Amlodipine Besylate-Benazepril30$1,604$53
Toprol Xl14$1,451$104
Simvastatin115$1,207$10
Torsemide26$1,024$39
Coumadin11$972$88
Diltiazem 24hr Cd29$882$30
Furosemide164$853$5
Losartan-Hydrochlorothiazide43$757$18
Cilostazol18$729$40
Taztia Xt11$703$64
Spironolactone35$452$13
Digox49$445$9
Fenofibrate16$438$27
Digoxin26$429$17
Nitrostat30$400$13
Lisinopril-Hydrochlorothiazide40$396$10
Isosorbide Mononitrate Er26$364$14
Pantoprazole20$324$16
Felodipine Er12$268$22
Omeprazole12$256$21
Hydrochlorothiazide43$217$5
Metoprolol25$210$8
Lovastatin11$173$16
Atenolol17$120$7

Money from drug and device companies

$198 in 2025

Industry payments by year
202522None$198
202322None$133
202222None$64
202111None$40
201911None$102

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
W. L. Gore & AssociatesGore Cardioform Septal Occluder$163
1 payment
  • Meals for Gore Cardioform Septal Occluder · 2025-02-18 · $163
Novartis PharmaceuticalsLeqvio$35
1 payment
  • Meals for Leqvio · 2025-04-28 · $35
See all 2 published payments
Every published payment
Novartis PharmaceuticalsMeals · 2025-04-28Leqvio$35
W. L. Gore & AssociatesMeals · 2025-02-18Gore Cardioform Septal Occluder$163
See earlier years (2023, 2022, 2021, 2019)

2023: $133

Payments by company in 2023
E.R. Squibb & Sons L.L.C.Camzyos$109
1 payment
  • Meals for Camzyos · 2023-10-27 · $109
Abbott LaboratoriesAmplatzer Amulet$24
1 payment
  • Meals for Amplatzer Amulet · 2023-12-19 · $24

2022: $64

Payments by company in 2022
Bardy DiagnosticsCarnation Ambulatory Monitor$37
1 payment
  • Meals for Carnation Ambulatory Monitor · 2022-08-15 · $37
Lantheus Medical ImagingDefinity$27
1 payment
  • Meals for Definity · 2022-11-03 · $27

2021: $40

Payments by company in 2021
Biosense WebsterCarto 3$40
1 payment
  • Meals for Carto 3 · 2021-12-06 · $40

2019: $102

Payments by company in 2019
Medtronic Vascular3f$102
1 payment
  • Meals for 3f · 2019-12-17 · $102

Checkups this office reported

11 measures · 2023

Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.

Medicare’s overall office score
88.8 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Checkup rates this office reported to Medicare
Asked about smokingPatients asked about tobacco, with help to quit if they smoke0%That's few of the people this applied to.563
Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range66%That's more than half.498
Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure95%22
Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high71%That's more than half. Worse on this measure.21
Medications listed in the chartVisits where the current medication list was documented95%That's most of the people this applied to.1,722
Patients can see their records onlinePatients who were given electronic access to their health information73%That's more than half.804
Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper97%That's most of the people this applied to.559
Risky medications in older adultsOlder patients given a medication that is risky at their age0%That's few of the people this applied to. Better on this measure.1,072
See the other 3 measures
More measures this office reported to Medicare
Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure23%988
Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin89%That's most of the people this applied to.585
Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed25%That's less than half.1,331

What the office says it does

Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.

  • Agreed to federal review of their records system
  • Did a security review of patient data
  • Exchanges records both ways with other health systems
  • High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
  • Implementation of medication management practice improvements
  • Improved the patient portal
  • Lets patients read their visit notes
  • ONC-ACB Surveillance Attestation
  • Reports cases to public health electronically
  • Reports immunizations to the state registry
  • Reports to a public-health or clinical registry
  • Uses standard treatment protocols
  • Exempt from query of the prescription drug monitoring program (pdmp)

Professional record

NPI
1679750574
Licence
CA A105051California A105051: Current · expires 2027-09-30
Trained
Rush Medical College of Rush University, 2002 · 24 years ago
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA GR0068680
Taxonomy
Cardiology (207RC0000X)
Mailing address
1370 Chorro St, San Luis Obispo, CA, 93401
NPI first listed
2008-01-23
NPI last updated
2025-10-03
NPI record certified
2025-10-03

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 850 Fair Oaks Ave Ste 100, Arroyo Grande, CA, 93420 · 1911 Johnson Ave, San Luis Obispo, CA, 93401 · 1941 Johnson Ave, San Luis Obispo, CA, 93401 · 1941 Johnson Ave Ste 102, San Luis Obispo, CA, 93401 · 295 Posada Ln Ste A, Templeton, CA, 93465